SCHEMBL560313

SCHEMBL560313

C=C(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 5/20 0.38
CHRM1 P11229 3/20 0.38
CHRM4 P08173 2/20 0.38
CHRM3 P20309 2/20 0.38
CYP2D6 P10635 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TSHR P16473 2/20 0.35
ALOX15 P16050 1/20 0.35
CES2 O00748 1/20 0.35
EPHX1 P07099 3/20 0.34
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL560314 1.00 CHRM2 (0.38) CHRM2CHRM1CHRM4CHRM3CYP2D6
SCHEMBL12604928 0.89 EPHX1 (0.37) CES2EPHX1
SCHEMBL7732630 0.85 CHRM2 (0.40) CHRM2CHRM1CHRM4CHRM3CYP2D6
SCHEMBL938022 0.83 CHRM2 (0.39) CHRM2CHRM1CHRM4CHRM3CYP2D6
SCHEMBL938023 0.83 CHRM2 (0.39) CHRM2CHRM1CHRM4CHRM3CYP2D6
SCHEMBL4152009 0.83 CHRM2 (0.39) CHRM2CHRM1CHRM4CHRM3CYP2D6
SCHEMBL2157709 0.83 CHRM2 (0.39) CHRM2CHRM1CHRM4CHRM3CYP2D6
SCHEMBL5438205 0.83 CHRM2 (0.39) CHRM2CHRM1CHRM4CHRM3CYP2D6
SCHEMBL4155540 0.83 CHRM2 (0.39) CHRM2CHRM1CHRM4CHRM3CYP2D6
SCHEMBL5464867 0.83 CHRM2 (0.39) CHRM2CHRM1CHRM4CHRM3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 600 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260047994-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL SYMRISE AG (DE) 2026-02-19 US claimed
US-20250352444-A1 Antimicrobial mixtures SYMRISE AG (DE) 2025-11-20 US claimed
US-20250325463-A1 COMPOSITIONS (III) SYMRISE AG (DE) 2025-10-23 US claimed
EP-4622621-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL Symrise AG (DE) 2025-10-01 EP claimed
US-20250129312-A1 CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES PROCTER & GAMBLE (US) 2025-04-24 US claimed
CN-119592371-A Essence containing coffee and cocoa compound extract and preparation method thereof 茂名华美实业有限公司 2025-03-11 CN claimed
US-12209232-B2 Consumer product compositions with perfume encapsulates THE PROCTER & GAMBLE COMPANY (US) 2025-01-28 US claimed
EP-4472606-A1 COMPOSITIONS (III) Symrise AG (DE) 2024-12-11 EP claimed
CN-118873528-A Nebulizable substrate, use thereof and aerosol generating device 深圳芳芯科技有限公司 2024-11-01 CN claimed
CN-118873543-A Aerosol matrix, application thereof and aerosol generating device 深圳芳芯科技有限公司 2024-11-01 CN claimed
CN-108752163-B Method for synthesizing terpene diol from turpentine and preparing terpineol and acetate 广西壮族自治区林业科学研究院 2020-10-13 CN claimed
CN-111212884-A Cold-sensitive composition containing 2,2, 6-trimethylcyclohexanecarboxylic acid derivative 高砂香料工业株式会社 2020-05-29 CN claimed
CN-111109647-A Flavor composition and electronic cigarette liquid containing same 深圳雾芯科技有限公司 2020-05-08 CN claimed
CN-111109646-A Flavor composition and electronic cigarette liquid containing same 深圳雾芯科技有限公司 2020-05-08 CN claimed
CN-111084407-A Flavor composition and electronic cigarette liquid containing same 深圳雾芯科技有限公司 2020-05-01 CN claimed
CN-111084408-A Flavor composition and electronic cigarette liquid containing same 深圳雾芯科技有限公司 2020-05-01 CN claimed
CN-111053282-A Flavor composition and electronic cigarette liquid containing same 深圳雾芯科技有限公司 2020-04-24 CN claimed
CN-111053281-A Flavor composition and electronic cigarette liquid containing same 深圳雾芯科技有限公司 2020-04-24 CN claimed
CN-111053283-A Flavor composition and electronic cigarette liquid containing same 深圳雾芯科技有限公司 2020-04-24 CN claimed
CN-107532063-B Methylmenthol derivative and cold-sensitive composition containing the same 高砂香料工业株式会社 2020-03-10 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250352444-A1 Antimicrobial mixtures LRBA, MGLL, TAS2R50 CHRM2 4594/4885CHRM1 4395/4885CHRM4 4412/4885
US-20260047994-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL RBP4, LRAT, RARB CHRM2 1752/4885CHRM1 1989/4885CHRM4 1228/4885
US-20250325463-A1 COMPOSITIONS (III) NISCH, TAS1R3, TAS2R3 CHRM2 2196/4885CHRM1 1618/4885CHRM4 2299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.